---
title: "CISEN released its semi-annual performance report, with a net profit attributable to the parent company of 229 million yuan, a year-on-year decrease of 15.23%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254843764.md"
description: "According to the Zhitong Finance APP, CISEN disclosed its semi-annual report for 2025. During the reporting period, the company achieved revenue of 1.74 billion yuan, a year-on-year decrease of 15.97%; net profit attributable to shareholders was 229 million yuan, a year-on-year decrease of 15.23%; net profit excluding non-recurring items was 180 million yuan, a year-on-year decrease of 24.08%; basic earnings per share were 0.51 yuan. The company plans to distribute a cash dividend of 0.188 yuan per share (tax included) to all shareholders"
datetime: "2025-08-27T14:15:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254843764.md)
  - [en](https://longbridge.com/en/news/254843764.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254843764.md)
---

# CISEN released its semi-annual performance report, with a net profit attributable to the parent company of 229 million yuan, a year-on-year decrease of 15.23%

According to the Zhitong Finance APP, CISEN (603367.SH) disclosed its semi-annual report for 2025. During the reporting period, the company achieved revenue of 1.74 billion yuan, a year-on-year decrease of 15.97%; net profit attributable to shareholders was 229 million yuan, a year-on-year decrease of 15.23%; net profit excluding non-recurring items was 180 million yuan, a year-on-year decrease of 24.08%; basic earnings per share were 0.51 yuan. The company plans to distribute a cash dividend of 0.188 yuan per share (tax included) to all shareholders

### Related Stocks

- [603367.CN](https://longbridge.com/en/quote/603367.CN.md)

## Related News & Research

- [Jeff Bezos Says SpaceX IPO Could Help Entire Sector: 'Space Is Going To Be A Gigantic Industry'](https://longbridge.com/en/news/287092627.md)
- [Lytix Biopharma Advances Ruxotemitide Program as Q1 2026 Results Underscore Oncology Focus](https://longbridge.com/en/news/287162474.md)
- [Hisense Home Appliances Deploys RMB1.81 Billion into Chongqing Trust Wealth Products](https://longbridge.com/en/news/286888326.md)
- [Strix Discloses Trust-Led Share Tender by Non-Executive Director](https://longbridge.com/en/news/286884952.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)